. Although the severe course of COVID-19 can be prevented using appropriate treatments, effective

prognosis and difficult to treat. Despite significant advances in the treatment of ccRCC, immune checkpoint

of pronounced morphologic changes, which makes treatment difficult. In this regard, an important task

as changes in the structure and approaches to the treatment of oncological diseases, which, in their turn

of the cardiovascular, nervous systems, diabetes mellitus, as well as the development of possible treatment options

One of the directions in treatment of chemoresistant breast cancer (BC) may include new methods

activity was determined by comparing tumor growth inhibition (TGI) in the treatment groups